Laurus Labs Q2 net profit surges on 33% rise in revenue
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
Attributed summary
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
Read the original report — The Hindu Business
Storywire publishes attributed summaries for discoverability. Full reporting remains with the original publisher — we do not republish restricted full text.
